Literature DB >> 1597005

Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue.

J G de Jong1, R A Wevers, R Liebrand-van Sambeek.   

Abstract

Earlier we described a simple and reliable screening procedure in urine for mucopolysaccharidoses based on the color reaction of glycosaminoglycans (GAGs) with dimethylmethylene blue. At physiological concentrations of urinary protein, we observed an obvious interference by protein in the assay. By modifying the assay, we abolished the protein interference. The modified procedure is not disturbed by human serum albumin, IgG (both tested with as much as 5 g/L of protein), or urinary proteins. The modified procedure appeared as reliable as the original. No false-negative results were found in a series of 26 urine samples from patients with mucopolysaccharidoses (sensitivity 100%). In a series of 405 urine samples offered for metabolic screening, 24 samples with increased GAG content and normal GAG composition were seen (specificity 94%). The method may also be applicable for determining GAG in other body fluids or solutions containing protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597005

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  36 in total

1.  Screening for Attenuated Forms of Mucopolysaccharidoses in Patients with Osteoarticular Problems of Unknown Etiology.

Authors:  Thabata Caroline da Rocha Siqueira; Carolina Fischinger Moura de Souza; Paulo Lompa; Mercedes Picarelli; Ilóite Scheibel; Fernanda Bender; Régis Guidobono; Maira Graeff Burin; Roberto Giugliani
Journal:  JIMD Rep       Date:  2015-08-28

2.  Glycosaminoglycan excretion in children with nephrotic syndrome.

Authors:  Nurcan Cengiz; Aysun K Bayazit; Aytul Noyan; Ruksan Anarat; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2005-02-16       Impact factor: 3.714

3.  Urinary Glycosaminoglycan Estimation as a Routine Clinical Service.

Authors:  M B Dave; P K Chawla; A J Dherai; T F Ashavaid
Journal:  Indian J Clin Biochem       Date:  2014-07-27

4.  Early Umbilical Cord Blood-Derived Stem Cell Transplantation Does Not Prevent Neurological Deterioration in Mucopolysaccharidosis Type III.

Authors:  Lindsey Welling; Jan Pieter Marchal; Peter van Hasselt; Ans T van der Ploeg; Frits A Wijburg; Jaap Jan Boelens
Journal:  JIMD Rep       Date:  2014-09-26

5.  Reliability of a visual test for the rapid detection of mucopolysaccharidoses: GAG-test(®).

Authors:  Sergio Lage; José A Prieto; Fernando Andrade; Amaia Sojo; Pablo Sanjurjo; Luis J Aldámiz-Echevarría
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

6.  Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.

Authors:  P Delannoy; I Kim; N Emery; C De Bolos; A Verbert; P Degand; G Huet
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 7.  Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.

Authors:  Monique Piraud; Magali Pettazzoni; Pamela Lavoie; Séverine Ruet; Cécile Pagan; David Cheillan; Philippe Latour; Christine Vianey-Saban; Christiane Auray-Blais; Roseline Froissart
Journal:  J Inherit Metab Dis       Date:  2018-03-19       Impact factor: 4.982

8.  The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome).

Authors:  A R Garcia; J Pan; J C Lamsa; J Muenzer
Journal:  J Inherit Metab Dis       Date:  2007-09-16       Impact factor: 4.982

9.  Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.

Authors:  Tsutomu Shimada; Joan Kelly; William A LaMarr; Naomi van Vlies; Eriko Yasuda; Robert W Mason; William Mackenzie; Francyne Kubaski; Roberto Giugliani; Yasutsugu Chinen; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji E Orii; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2014-07-21       Impact factor: 4.797

10.  Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease.

Authors:  J de Ruijter; L Ijlst; W Kulik; H van Lenthe; T Wagemans; N van Vlies; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2012-09-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.